Absci Corporation, a leading biotech stock, combines deep learning with lab automation to design biologics at scale. The company recently expanded its partnership with Almirall to target chronic skin diseases and appointed experts for hair loss therapy. Collaboration with Oracle and AMD will enhance AI-driven drug discovery capabilities.

Absci Corporation secured $64 million in equity financing to drive AI drug discovery through 2028. The funding will support key pipeline programs and accelerate partnered projects. While Absci offers investment potential, other AI stocks may offer greater upside with less downside risk. Explore potential opportunities with the best short-term AI stock.

Read more at Yahoo Finance: Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028